Related Experiment Video
Updated: Dec 10, 2025

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy
Mostafa Abdelsalam1, A M Wahab1, Maysaa El Sayed Zaki2
1Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Background:
Diabetes mellitus is the leading cause of end-stage renal disease worldwide. Microalbuminuria is the cornerstone for the diagnosis of diabetic nephropathy. However, it is an inadequate marker for early diagnosis. MicroRNAs are not only new and promising markers for early diagnosis but also, but they may also play a role in the prevention of disease progression.
Methods:
This study included ninety patients with type 2 DM in addition to 30 control subjects. MicroRNA-451 expression in blood and plasma using real-time PCR was evaluated in addition to the classic diabetic nephropathy markers (serum creatinine, urinary albumin, and eGFR).
Results:
There was a significant difference between the studied groups versus control regarding serum creatinine, eGFR, urinary, and plasma microRNA-451 with p=0.0001. Patients with eGFR 60 ml/min/1.73 m2 showed a significantly higher plasma microRNA-451 (29.6 ± 1.6) and significantly lower urinary microRNA-451 (21 ± 0.9) in comparison to patients with eGFR >60 ml/min/1.73 m2 and p=0.0001. eGFR showed a positive correlation with urinary microRNA-451 and negative correlation with both plasma microRNA-451 and urinary albumin. Both plasma and urinary microRNA-451 are highly sensitive and specific markers for chronicity in diabetic nephropathy patients with sensitivity of 90.9% and 95.5% and specificity of 67.6% and 95.6%, respectively.
Conclusion:
MicroRNA-451 is a promising early biomarker for chronic kidney disease in diabetic nephropathy with high sensitivity and specificity.
Insights
MicroRNA-451 shows potential as an early diagnostic marker for diabetic nephropathy, offering higher sensitivity and specificity than traditional markers for chronic kidney disease. This microRNA can aid in early detection and management of kidney complications in diabetes patients.
Area of Science:
- Biochemistry
- Genetics
- Nephrology
Background:
- Diabetes mellitus is a primary cause of end-stage renal disease globally.
- Microalbuminuria is a key diagnostic marker for diabetic nephropathy but lacks early diagnostic sensitivity.
- MicroRNAs are emerging as potential early diagnostic markers and therapeutic targets for diabetic nephropathy progression.
Purpose of the Study:
- To evaluate microRNA-451 as an early diagnostic biomarker for diabetic nephropathy.
- To compare microRNA-451 expression levels with traditional markers of kidney function in type 2 diabetes patients.
Main Methods:
- Ninety patients with type 2 diabetes and 30 controls were included.
- Real-time PCR was used to measure microRNA-451 expression in blood and plasma.
- Serum creatinine, urinary albumin, and estimated glomerular filtration rate (eGFR) were assessed as standard markers.
Main Results:
- Significant differences in serum creatinine, eGFR, and microRNA-451 levels were observed between diabetic patients and controls (p=0.0001).
- Lower eGFR (<60 ml/min/1.73 m²) correlated with higher plasma microRNA-451 and lower urinary microRNA-451 (p=0.0001).
- Plasma and urinary microRNA-451 demonstrated high sensitivity and specificity for detecting chronic kidney disease in diabetic nephropathy.
Conclusions:
- MicroRNA-451 is a promising early biomarker for chronic kidney disease in diabetic nephropathy.
- Its high sensitivity and specificity suggest a valuable role in early diagnosis and disease monitoring.
- MicroRNA-451 may contribute to better management strategies for diabetic kidney disease.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

